LUXSOL(TM) Topical Cream for the Treatment of Symptomatic Bacterial Vaginosis; A Proof of Concept Study

Inclusion Criteria: * Subject agrees to participate and signs informed consent * Female age 18 or older * Subject has clinical BV with 4 of 4 Amsel's criteria * Off-white (milky or gray), thin, adherent, homogenous discharge with minimal or absent pruritus and inflammation of the vulva and vagina * Presence of 'clue cells' \>/=20% of the total epithelial cells on microscopic examination of the saline 'wet mount.' * Virginal secretion pH of \>4.5 * A fishy odor of the vaginal discharge with the addition of a drop of 10% KOH (i.e. a positive 'whiff test') * Subject agrees to refrain from use of douches, intravaginal products for treatment period * Subject agrees to refrain from taking oral or intravaginal antibiotics or antifungal agents during entire study period * Subject agrees to refrain from vaginal intercourse during treatment period. Exclusion Criteria: * Subject has another infectious or noninfectious cause of vulvovaginitis * Subject has another vaginal or vulvar condition that would confound the determination of study endpoints. * Subject has received antifungal or antimicrobial therapy (systemic or intravaginal) within the last 14 days prior to enrollment. * Subject is under treatment for cervical intra-epithelial neoplasia or cervical carcinoma * Subject is known to be HIV positive * Subject has a positive pregnancy test * Subject has any abnormal anatomy or pathology of the vagina * Subject has untreated sexually transmitted disease * Subject is currently having menstrual period or may have her period during treatment days. * Subject's PAP smear \>/= to LSIL * Subjects with known sensitivity or allergic reactions to copper or Metronidazole vaginal gel * Subject has known Wilson's disease